v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS(Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash Flows From Operating Activities    
Net loss $ (6,019,824) $ (9,864,298)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock based compensation 179,493 1,022,894
Depreciation and amortization 1,287,048 1,300,697
Impairment of property & equipment 360,151 1,674,000
Loss on lease termination 57,903
Loss on sale of property & equipment 135,603 172,564
Gain on sale of R&D assets (50,097)
Amortization of right-of-use asset 292,867 359,246
Net change in fair value of marketable securities (5,204)
Change in inventory reserve 67,859 (293,059)
Accounts receivable (312,993) (49,384)
Inventories (13,240) 1,884,449
Prepaid expenses and other current assets (55,100) (84,855)
Accounts payable (805,007) (441,124)
Accrued liabilities (195,209) 120,470
Operating lease liabilities (327,402) (379,166)
Contract liabilities 217,887 (6,020)
Net cash used in operating activities (5,129,964) (4,638,887)
Cash Flows From Investing Activities    
Security deposit 14,087 2,707
Realized gain on sale of marketable securities, available for sale (35,210)
Net sales of investment in marketable securities 4,503,356
Proceeds from sale of property & equipment 52,478 6,000
Purchase of property and equipment (2,016,927) (5,044,742)
Net cash used in investing activities (1,950,362) (567,889)
Cash Flows From Financing Activities    
Proceeds from issuance of common stock, net of fees of $444,899 2,555,101
Deferred offering costs (151,088)
Finance lease payments (110,239) (190,565)
Net cash provided by (used in) financing activities 2,293,774 (190,565)
Net change in cash, cash equivalents and restricted cash (4,786,552) (5,397,341)
Cash, cash equivalents and restricted cash at beginning of the period 7,706,240 16,755,233
Cash, cash equivalents and restricted cash at end of the period 2,919,688 11,357,892
Supplemental Cash Flow Information    
Cash paid for interest 257,778 327,879
Non-Cash Investing and Financing Activities    
Increase in the right-of-use asset and lease liability 31,572
Reconciliation to the Condensed Consolidated Balance Sheets    
Cash and cash equivalents 2,704,571 11,144,929
Restricted cash 215,117 212,963
Total cash, cash equivalents and restricted cash $ 2,919,688 $ 11,357,892

Source

PDF HTML
10-Q Filing
ZIP HTML
XBRL